Al Jarroudi O, El Bairi K, Curigliano G, Afqir S
Cancer Treat Res. 2024; 188:1-27.
PMID: 38175340
DOI: 10.1007/978-3-031-33602-7_1.
Lu L, Niu Z, Chao Z, Fu C, Chen K, Shi Y
Cell Mol Life Sci. 2023; 80(12):350.
PMID: 37930428
PMC: 11073441.
DOI: 10.1007/s00018-023-04946-x.
Nader-Marta G, Molinelli C, Debien V, Martins-Branco D, Aftimos P, de Azambuja E
Ther Adv Med Oncol. 2023; 15:17588359231183679.
PMID: 37435563
PMC: 10331351.
DOI: 10.1177/17588359231183679.
Abu-Elmagd M, Assidi M, Alrefaei A, Rebai A
Front Cell Dev Biol. 2022; 10:1016400.
PMID: 36478744
PMC: 9720382.
DOI: 10.3389/fcell.2022.1016400.
Jones S, Farr G, Nimmanon T, Ziliotto S, Gee J, Taylor K
Explor Target Antitumor Ther. 2022; 3(2):224-239.
PMID: 35591900
PMC: 7612740.
DOI: 10.37349/etat.2022.00080.
Development of camelid monoclonal nanobody against SLC39A6 zinc transporter protein.
Ghaderi H, Noormohammadi Z, Habibi-Anbouhi M, Kazemi-Lomedasht F, Behdani M
Iran J Basic Med Sci. 2022; 24(12):1726-1733.
PMID: 35432806
PMC: 8976899.
DOI: 10.22038/IJBMS.2021.58542.13003.
STAT3 pathway in cancers: Past, present, and future.
Wang H, Man Q, Huo F, Gao X, Lin H, Li S
MedComm (2020). 2022; 3(2):e124.
PMID: 35356799
PMC: 8942302.
DOI: 10.1002/mco2.124.
Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer.
Althobiti M, El-Sharawy K, Joseph C, Aleskandarany M, Toss M, Green A
Breast Cancer Res Treat. 2021; 189(3):621-630.
PMID: 34453638
PMC: 8505289.
DOI: 10.1007/s10549-021-06336-y.
The ZIP6/ZIP10 heteromer is essential for the zinc-mediated trigger of mitosis.
Nimmanon T, Ziliotto S, Ogle O, Burt A, Gee J, Andrews G
Cell Mol Life Sci. 2020; 78(4):1781-1798.
PMID: 32797246
PMC: 7904737.
DOI: 10.1007/s00018-020-03616-6.
Novel antibody-drug conjugates for triple negative breast cancer.
Nagayama A, Vidula N, Ellisen L, Bardia A
Ther Adv Med Oncol. 2020; 12:1758835920915980.
PMID: 32426047
PMC: 7222243.
DOI: 10.1177/1758835920915980.
ZIP4 Promotes Pancreatic Cancer Progression by Repressing ZO-1 and Claudin-1 through a ZEB1-Dependent Transcriptional Mechanism.
Liu M, Yang J, Zhang Y, Zhou Z, Cui X, Zhang L
Clin Cancer Res. 2018; 24(13):3186-3196.
PMID: 29615456
PMC: 7006048.
DOI: 10.1158/1078-0432.CCR-18-0263.
Antibody-Drug Conjugates for the Treatment of Solid Tumors: Clinical Experience and Latest Developments.
Nagayama A, Ellisen L, Chabner B, Bardia A
Target Oncol. 2017; 12(6):719-739.
PMID: 29116596
DOI: 10.1007/s11523-017-0535-0.
miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma.
Lian J, Jing Y, Dong Q, Huan L, Chen D, Bao C
Oncotarget. 2015; 7(3):2672-83.
PMID: 26684241
PMC: 4823063.
DOI: 10.18632/oncotarget.6603.
SLC39A6: a potential target for diagnosis and therapy of esophageal carcinoma.
Cui X, Shen Y, Jin T, Li S, Li T, Zhang S
J Transl Med. 2015; 13:321.
PMID: 26444413
PMC: 4595240.
DOI: 10.1186/s12967-015-0681-z.
ZIP4, a novel determinant of tumor invasion in hepatocellular carcinoma, contributes to tumor recurrence after liver transplantation.
Xu X, Guo H, Xie H, Li J, Zhuang R, Ling Q
Int J Biol Sci. 2014; 10(3):245-56.
PMID: 24643086
PMC: 3957080.
DOI: 10.7150/ijbs.7401.
A mechanism for epithelial-mesenchymal transition and anoikis resistance in breast cancer triggered by zinc channel ZIP6 and STAT3 (signal transducer and activator of transcription 3).
Hogstrand C, Kille P, Ackland M, Hiscox S, Taylor K
Biochem J. 2013; 455(2):229-37.
PMID: 23919497
PMC: 3789231.
DOI: 10.1042/BJ20130483.
Genome-wide association study identifies common variants in SLC39A6 associated with length of survival in esophageal squamous-cell carcinoma.
Wu C, Li D, Jia W, Hu Z, Zhou Y, Yu D
Nat Genet. 2013; 45(6):632-8.
PMID: 23644492
DOI: 10.1038/ng.2638.
Negative correlation of LIV-1 and E-cadherin expression in hepatocellular carcinoma cells.
Shen R, Xie F, Shen H, Liu Q, Zheng T, Kou X
PLoS One. 2013; 8(2):e56542.
PMID: 23437163
PMC: 3577881.
DOI: 10.1371/journal.pone.0056542.
Gene profile identifies zinc transporters differentially expressed in normal human organs and human pancreatic cancer.
Yang J, Zhang Y, Cui X, Yao W, Yu X, Cen P
Curr Mol Med. 2013; 13(3):401-9.
PMID: 23331012
PMC: 3799886.
Zinc and cancer: implications for LIV-1 in breast cancer.
Grattan B, Freake H
Nutrients. 2012; 4(7):648-75.
PMID: 22852056
PMC: 3407987.
DOI: 10.3390/nu4070648.